Literature DB >> 16784419

Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.

Axel Buob1, Jens Jung, Stephanos Siaplaouras, Hans-Ruprecht Neuberger, Christian Mewis.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) and C-reactive protein (CRP) have been suggested to be prognostically relevant markers in patients with cardiovascular disease. Additionally, BNP and CRP plasma levels seem to be independently elevated in patients with atrial fibrillation (AF). However, there are only sparse data about the significance and temporal course of these plasma markers after restoration of sinus rhythm (SR).
METHODS: We performed a prospective study in consecutive patients with symptomatic atrial fibrillation. NT-proBNP and CRP plasma levels were measured before and one month after electrical cardioversion (CV). Patients with infections, an acute coronary syndrome, or surgery 4 weeks prior to CV, were excluded. RESULT: Twenty-five patients (men 84%, age 66 +/- 8 years, duration of AF 90 +/- 75 days, left ventricular ejection fraction 0.57 +/- 0.11) were analyzed. At follow-up (33 +/- 6 days after CV) 14 patients (56%) were in SR and 11 patients (44%) in AF. In patients with SR there was a significant reduction of NT-proBNP levels (baseline 1647 +/- 1272 pg/mL, follow-up 772 +/- 866 pg/mL, P < 0.05), even in a subgroup of patients (n = 10) with normal left ventricular ejection fraction (1262 +/- 538 vs 413 +/- 344 pg/mL, P < 0.001). CRP levels in patients with SR were similar at baseline and at follow-up (3.5 +/- 3.6 vs 3.2 +/- 2.5 mg/L, P = 0.8).
CONCLUSION: We conclude that even in patients with normal left ventricular ejection fraction restoration of sinus rhythm leads to a significant reduction of NT-proBNP plasma levels. In contrast, CRP plasma levels seem not to be influenced during the first 4 weeks after electrical cardioversion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784419     DOI: 10.1111/j.1540-8159.2006.00401.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  9 in total

1.  NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.

Authors:  Jinqi Fan; Hua Cao; Li Su; Zhiyu Ling; Zengzhang Liu; Xianbin Lan; Yanping Xu; Weijie Chen; Yuehui Yin
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis.

Authors:  Mehmet Ozaydin; Yasin Turker; Ercan Varol; Sule Alaca; Dogan Erdogan; Nigar Yilmaz; Abdullah Dogan
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

3.  Markers of inflammation before and after curative ablation of atrial flutter.

Authors:  Gregory M Marcus; Lisa M Smith; David V Glidden; Emily Wilson; Jamie M McCabe; Dean Whiteman; Zian H Tseng; Nitish Badhwar; Byron K Lee; Randall J Lee; Melvin M Scheinman; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2007-10-07       Impact factor: 6.343

4.  Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block.

Authors:  Brigitte Lampe; Christoph Hammerstingl; Jörg Otto Schwab; Fritz Mellert; Birgit Stoffel-Wagner; Andreas Grigull; Rolf Fimmers; Bernhard Maisch; Georg Nickenig; Thorsten Lewalter; Alexander Yang
Journal:  Clin Res Cardiol       Date:  2012-05-16       Impact factor: 5.460

5.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

Review 6.  Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis.

Authors:  Xiangdong Xu; Yongqing Tang
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

7.  N-terminal pro-brain natriuretic peptide and atrial fibrillation.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07

Review 8.  Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis.

Authors:  Chia-Hung Yo; Si-Huei Lee; Shy-Shin Chang; Matthew Chien-Hung Lee; Chien-Chang Lee
Journal:  BMJ Open       Date:  2014-02-20       Impact factor: 2.692

9.  NT Pro-BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement.

Authors:  Xiao Zhao; Hao Li; Cai Liu; Yuanyuan Ren; Chaofeng Sun
Journal:  Clin Cardiol       Date:  2021-12-24       Impact factor: 2.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.